Management of Dexamethasone-Induced Hyperglycemia

Understanding Steroid-Induced Hyperglycemia

Dexamethasone is a long-acting glucocorticoid that significantly increases blood glucose levels, with hyperglycemic effects lasting throughout the day 1
Glucocorticoid therapy can induce hyperglycemia in 56-86% of hospitalized patients with and without preexisting diabetes 1
Untreated steroid-induced hyperglycemia increases mortality and morbidity risk, including infections and cardiovascular events 1

NPH insulin is specifically recommended for steroid-induced hyperglycemia due to its intermediate-acting profile that peaks at 4-6 hours, aligning with the peak hyperglycemic effect of glucocorticoids 1, 2
For patients on dexamethasone, a combination approach is often needed that includes both long-acting insulin and NPH insulin 1, 3

Initial NPH insulin dosing should be 0.1-0.2 units/kg per day administered in the morning to coincide with dexamethasone administration 2, 3
For patients on high-dose glucocorticoids like dexamethasone, insulin requirements may increase by 40-60% above standard dosing 1, 3
Consider increasing the total daily insulin dose to 0.3-0.5 units/kg for insulin-naive patients, with half allocated to basal insulin and half to rapid-acting insulin 4

Monitor blood glucose every 2-4 hours while the patient is hospitalized to guide insulin adjustments 2, 3
For persistent hyperglycemia, increase NPH dose by 2 units every 3 days until target blood glucose is achieved 2, 3
Target blood glucose range should be 100-180 mg/dL (5.6-10.0 mmol/L) 1

Avoid relying solely on sliding scale insulin: Sliding scale insulin alone is associated with poor glycemic control and has been discouraged in clinical guidelines 4
Beware of hypoglycemia risk: When adjusting insulin doses, monitor closely for hypoglycemia, especially in patients with decreased oral intake 4
Consider the duration of steroid therapy: Insulin requirements typically decrease rapidly after steroid discontinuation, requiring prompt dose adjustments to avoid hypoglycemia 3

For patients receiving enteral/parenteral nutrition while on steroids, NPH insulin can be administered two or three times daily (every 8 or 12 hours) 1, 5
A basal-bolus approach has been shown to be more effective than sliding scale insulin alone in managing steroid-induced hyperglycemia 4

Perform point-of-care glucose monitoring before meals and at bedtime to assess the effectiveness of the insulin regimen 1, 5
Adjust insulin doses daily based on glucose patterns and anticipated changes in glucocorticoid dosing 1
Pay special attention to afternoon and evening glucose values, which tend to be highest with morning steroid administration 3